Tandem Diabetes (TNDM) Misses Q2 EPS by 82c, Revenues Beat; Offers FY18 Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Tandem Diabetes (TNDM) Misses Q2 EPS by 82c, Revenues Beat; Offers FY18 Revenue Outlook

Tandem Diabetes Care (TNDM) PT Raised to $28 at Cowen

July 31, 2018 6:25 AM EDT

Cowen raised its price target on Tandem Diabetes Care (NASDAQ: TNDM) to $28.00 (from $25.00) while maintaining an Outperform rating following beat and raise.

Analyst Doug Schenkel commented, "TNDM posted a big revenue beat and guidance raise; we expect upside to continue through 2019/2020 and increased... More